These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 9484875

  • 1. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE, Cranfield R, Breisch S, Pettit R.
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():63-72. PubMed ID: 9484875
    [Abstract] [Full Text] [Related]

  • 2. Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia.
    O'Doherty B, Dutchman DA, Pettit R, Maroli A.
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():73-81. PubMed ID: 9484876
    [Abstract] [Full Text] [Related]

  • 3. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE, Zuck P, Vogel F, McIvor A, Peirzchala W, Smakal M, Staley H, Marr C.
    J Antimicrob Chemother; 1999 Oct; 44(4):515-23. PubMed ID: 10588313
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA, Bettis R, Munk ZM, Fleming H, Munn NJ, Riffer E, Bagby B, Giguere G, Collins JJ.
    Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
    Chodosh S, Lakshminarayan S, Swarz H, Breisch S.
    Antimicrob Agents Chemother; 1998 Jan; 42(1):114-20. PubMed ID: 9449270
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables.
    Tran JQ, Ballow CH, Forrest A, Hyatt JM, Sands MF, Peloquin CA, Schentag JJ.
    J Antimicrob Chemother; 2000 Mar; 45():9-17. PubMed ID: 10719007
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis.
    Forrest A, Chodosh S, Amantea MA, Collins DA, Schentag JJ.
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():45-57. PubMed ID: 9484873
    [Abstract] [Full Text] [Related]

  • 8. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
    DeAbate CA, Henry D, Bensch G, Jubran A, Chodosh S, Harper L, Tipping D, Talbot GH.
    Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
    [Abstract] [Full Text] [Related]

  • 9. Randomized, double-blind, double-dummy study comparing the efficacy and safety of amoxycillin 1 g bd with amoxycillin 500 mg tds in the treatment of acute exacerbations of chronic bronchitis.
    Georgopoulos A, Borek M, Ridl W, Amoxycillin Bronchitis Study Group.
    J Antimicrob Chemother; 2001 Jan; 47(1):67-76. PubMed ID: 11152433
    [Abstract] [Full Text] [Related]

  • 10. Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis.
    Klietmann W, Cesana M, Rondel RK, Focht J.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2298-306. PubMed ID: 8285609
    [Abstract] [Full Text] [Related]

  • 11. Treatment of acute exacerbations of chronic bronchitis: comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study. Trovafloxacin Bronchitis Study Group.
    O'Doherty B, Daniel R.
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):441-6. PubMed ID: 9758290
    [Abstract] [Full Text] [Related]

  • 12. Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis.
    Grassi C, Salvatori E, Rosignoli MT, Dionisio P, Prulifloxacin Study Group.
    Respiration; 2002 Jun; 69(3):217-22. PubMed ID: 12097764
    [Abstract] [Full Text] [Related]

  • 13. Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study.
    Allegra L, Konietzko N, Leophonte P, Hosie J, Pauwels R, Guyen JN, Petitpretz P.
    J Antimicrob Chemother; 1996 May; 37 Suppl A():93-104. PubMed ID: 8737129
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of grepafloxacin 600 mg daily for 10 days in patients with community-acquired pneumonia.
    Topkis S, Swarz H, Breisch SA, Maroli AN.
    Clin Ther; 1997 May; 19(5):975-88. PubMed ID: 9385485
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
    Gotfried MH, Ellison WT.
    Am J Med; 1992 Apr 06; 92(4A):108S-113S. PubMed ID: 1316059
    [Abstract] [Full Text] [Related]

  • 16. Grepafloxacin: an overview of antibacterial activity, pharmacokinetics, clinical efficacy and safety.
    Geddes AM.
    Expert Opin Investig Drugs; 1999 Apr 06; 8(4):487-505. PubMed ID: 15992094
    [Abstract] [Full Text] [Related]

  • 17. The activity of grepafloxacin against respiratory pathogens in the UK.
    Wise R, Andrews JM.
    J Antimicrob Chemother; 1997 Dec 06; 40 Suppl A():27-30. PubMed ID: 9484870
    [Abstract] [Full Text] [Related]

  • 18. A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology.
    Kemper P, Köhler D.
    Am J Med; 1992 Apr 06; 92(4A):98S-102S. PubMed ID: 1316079
    [Abstract] [Full Text] [Related]

  • 19. Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study group.
    File T, Schlemmer B, Garau J, Lode H, Lynch S, Young C.
    J Chemother; 2000 Aug 06; 12(4):314-25. PubMed ID: 10949981
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.